Evaluation of the efficacy of a low-dose corticosteroid, associated with mycophenolic acid (Myfortic) in the attack treatment of nephrotic syndrome with minimal adult glomerular lesions

Trial Profile

Evaluation of the efficacy of a low-dose corticosteroid, associated with mycophenolic acid (Myfortic) in the attack treatment of nephrotic syndrome with minimal adult glomerular lesions

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Mycophenolate sodium (Primary)
  • Indications Nephrotic syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2017 This trial has been completed in France (on 2015-09-21), according to European Clinical Trials Database
    • 24 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top